A UK company that is Europe’s leading silicone rubber manufacturer has successfully targeted new markets in Latin America thanks to direct support provided by Santander and Medilink UK.
Primasil, the Herefordshire-based supplier of silicone products and materials to multiple industries all over the world, recently attended ExpoMED 2016 on a UK Pavilion organised by Medilink UK, in association with Santander.
Held at the World Trade Centre in Mexico City, ExpoMED 2016 is the largest healthcare event held in the developing Mexican healthcare sector.
Santander provided Primasil with a £2000 grant plus comprehensive pre-mission support and assistance. As a result the company was able to showcase a range of silicone products at the exhibition, including micro-bore and thin walled medical tubing, a vast array of extruded profiles, together with their moulding and injection moulding capabilities on articles from micro-moulding and over-moulding, up to much larger components, such as stipple matts. All of which also highlight the varying properties available of silicone rubber grades.
Caroline Herdman, Primasil Medical Divisional Manager, explained how the company came to the decision to exhibit at ExpoMed. She said: “We had previously exhibited with Medilink at shows on mainland Europe and the confidence gained from this led to us looking further afield.
“Latin America is a completely new marketplace for us but we have been aware for some time that there is a demand for silicone in Mexico. Further discussion with UKTI confirmed that there is presently no silicone manufacturer in the country and therefore there is a potential gap in the market. When we considered this together with the support provided courtesy of Santander, it definitely made it a worthwhile opportunity for us.”
Jonathan Rostron, Head of Breakthrough, Santander UK said: “Santander was delighted to work in partnership with Medilink UK to be able to support a number of UK businesses to help access this potential new market as part of their ambitious international growth plans.”
Mauricio Munguia, Latam Desk Director for Santander UK accompanied the delegation to Mexico and concurred “Mexico is the largest medical device importer in Latin America and ExpoMED is the ideal place for UK companies to meet new distributors, agents, buyers and decision makers in this rapidly growing market. Our targeted approach of taking businesses from the same sector to a key Santander stronghold certainly helped ensure that we were able to support and connect the UK businesses to the right experts and trading partners. Through Santander Mexico, we will be able to continue to provide on-the-ground support both here in the UK and in Mexico, and I look forward to working with Primasil to help them progress the great leads made whilst on the mission.”
Ahead of the exhibition Primasil’s main objective was to develop new contacts, raise awareness of their capabilities and to engage with potential partner organisations. In addition to showcasing their own products, Primasil also demonstrated client products comprising their silicone, including the Paxman cooling cap, which is a proven to help combat chemotherapy-induced hair loss and can result in a high level of retention or completely preserve the hair.
Andrew Thomas, Primasil Business Development Manager, added: “At ExpoMed there was great interest in silicone and Primasil as a company, with lots of footfall to our stand throughout what was a very well attended show. It was particularly pleasing to see people still coming into the exhibition hall right up to the end of the very last day.
“All of the logistics around getting to the exhibition, setting up the stand and the hotel itself were very good and Santander were the perfect host. It was a great exhibition for us and we have lots of enquiries to follow-up on, so it was definitely worthwhile attending.”
The Mexican healthcare system is well developed in both the public and private sectors with significant scope for expansion and improvement. The Mexican government has committed $5.6bn as part of a plan to improve national infrastructure, and healthcare spending is scheduled to grow by 8.2% annually until 2018.